One in every 100 newborns has a heart problem. Until now, these babies were treated with the same devices used in adults. Little Vivian Andorf was just two hours old ...

Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in ...

Guidelines for hemodialysis access for acute renal failure patients may need revision, data suggest. WASHINGTON, D.C.—Primary placement of tunneled dialysis catheters (TDCs) in patients with acute ...

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today that it has received approval from the United ...

IRVINE, Calif., Feb. 4, 2019 /PRNewswire/ -- Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart ...

May 11, 2012 (Boston, Massachusetts) — Radiofrequency (RF) catheter ablation with pulmonary vein isolation is not only safe as a first-line treatment for paroxysmal or persistent atrial fibrillation ...

Camstent Ltd., the company applying proprietary bacteria-phobic polymer coatings to medical devices, has been notified of initial results from the first-in-man pilot study for its CE marked coated ...